Abstract:BACKGROUND: More people are seeking health information online than ever before and pharmaceutical companies are increasingly marketing their drugs through social media.OBJECTIVE: The aim was to examine two major concerns related to online direct-to-consumer pharmaceutical advertising: (1) how disclosing an affiliation with a pharmaceutical company affects how people respond to drug information produced by both health organizations and online commenters, and (2) how knowledge that health organizations control the display of user-generated comments affects consumer health knowledge and behavior.METHODS: We conducted a 2×2×2 between-subjects experiment (N=674). All participants viewed an infographic posted to Facebook by a health organization about a prescription allergy drug. Across conditions, the infographic varied in the degree to which the health organization and commenters appeared to be affiliated with a drug manufacturer, and the display of user-generated comments appeared to be controlled.RESULTS: Affiliation disclosure statements on a health organization's Facebook post increased perceptions of an organization-drug manufacturer connection, which reduced trust in the organization (point estimate -0.45, 95% CI -0.69 to -0.24) and other users who posted comments about the drug (point estimate -0.44, 95% CI -0.68 to -0.22). Furthermore, increased perceptions of an organization-manufacturer connection reduced the likelihood that people would recommend the drug to important others (point estimate -0.35, 95% CI -0.59 to -0.15), and share the drug post with others on Facebook (point estimate -0.37, 95% CI -0.64 to -0.16). An affiliation cue next to the commenters' names increased perceptions that the commenters were affiliated with the drug manufacturer, which reduced trust in the comments (point estimate -0.81, 95% CI -1.04 to -0.59), the organization that made the post (point estimate -0.68, 95% CI -0.90 to -0.49), the likelihood of participants recommending the drug (point estimate -0.61, 95% CI -0.82 to -0.43), and sharing the post with others on Facebook (point estimate -0.63, 95% CI -0.87 to -0.43). Cues indicating that a health organization removed user-generated comments from a post increased perceptions that the drug manufacturer influenced the display of the comments, which negatively affected trust in the comments (point estimate -0.35, 95% CI -0.53 to -0.20), the organization (point estimate -0.31, 95% CI -0.47 to -0.17), the likelihood of recommending the drug (point estimate -0.26, 95% CI -0.41 to -0.14), and the likelihood of sharing the post with others on Facebook (point estimate -0.28, 95% CI -0.45 to -0.15). (All estimates are unstandardized indirect effects and 95% bias-corrected bootstrap confidence intervals.)CONCLUSIONS: Concern over pharmaceutical companies hiding their affiliations and strategically controlling user-generated comments is well founded; these practices can greatly affect not only how viewers evaluate drug information online, but also how likely they are to propagate the information throughout their online and offline social networks.

Effects of image congruency on persuasiveness and recall in direct-to-consumer prescription drug advertising

Marketing Drugs, Marketing Health Care Relationships: A Content Analysis of Visual Cues in Direct-to-Consumer Prescription Drug Advertising

Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions

Visual images of prescription drug benefits in direct-to-consumer television advertisements

Direct-to-consumer prescription medication advertisements and obtaining prescriptions with or without a doctor's prescription

Disease Awareness and Prescription Drug Communications on Television: Evidence for Conflation and Misleading Product Impressions

Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003-2016

Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease

Disease-specific direct-to-consumer advertising for reminding consumers to take medications

Consumer’s Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence

Attitudes of Older Americans toward Direct-to-Consumer Advertising: Predictors of Impact

How Affiliation Disclosure and Control Over User-Generated Comments Affects Consumer Health Knowledge and Behavior: A Randomized Controlled Experiment of Pharmaceutical Direct-to-Consumer Advertising on Social Media

“See Your Doctor”: the Impact of Direct-to-consumer Advertising on Patients with Different Affliction Levels

Exploration of Effective Persuasive Strategies Used in Resisting Product Advertising: A Case Study of Adult Health Check-Ups

The risk-value trade-off: price and brand information impact consumers' intentions to purchase OTC drugs

Experimental Study of the Promotional Implications of Proprietary Prescription Drug Names

Effects of Disclosure, Placement Type, and Ad–Context Congruence on Brand and Advertising Recognition: An Exploration of CARE Model Processing

'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study

TV commercials for prescription drugs: a discourse analytic perspective

Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?

Under the Influence: Social Media Influencers’ Impact on Response to Corporate Reputation Advertising